Showing results (51-60 of 74) with videos related to
Sort By:
Pageof 8
Scientific Reports|December 11, 2019
DAXX mutations as potential genomic markers of malignant evolution in small nonfunctioning pancreatic neuroendocrine tumorsMauro Cives, Stefano Partelli, Raffaele Palmirotta, et al.Advances in Therapy|October 13, 2025
The Role of Radioligand Therapy in Gastroenteropancreatic Neuroendocrine Tumors: An Italian Expert OpinionSalvatore Tafuto, Secondo Lastoria, Francesco Panzuto, et al.NPJ Digital Medicine|December 23, 2025
ARTEMIS: a pilot study comparing AI-based and expert therapeutic decisions in simulated clinical cases of neuroendocrine neoplasmsGiuseppe Lamberti, Francesco Panzuto, Sara Massironi, et al.Journal for Immunotherapy of Cancer|June 28, 2022
Development of anti-somatostatin receptors CAR T cells for treatment of neuroendocrine tumorsBarbara Mandriani, Eleonora Pellè, Francesco Mannavola, et al.Journal of Neuroendocrinology|October 1, 2021
The psychological impact of COVID-19 pandemic on patients with neuroendocrine tumors: Between resilience and vulnerabilityEleonora Lauricella, Mauro Cives, Alessandra Bracigliano, et al.Journal of Clinical Medicine|December 23, 2023
Extrapulmonary Neuroendocrine Carcinomas: Current Management and Future PerspectivesSara Stumpo, Maria Giovanna Formelli, Irene Persano, et al.Journal of Endocrinological Investigation|October 12, 2024
Radioligand therapy in the therapeutic strategy for patients with gastro-entero-pancreatic neuroendocrine tumors: a consensus statement from the Italian Association for Neuroendocrine Tumors (Itanet), Italian Association of Nuclear Medicine (AIMN), Italian Society of Endocrinology (SIE), Italian Association of Medical Oncology (AIOM)Francesco Panzuto, Manuela Albertelli, Maria Luisa De Rimini, et al.Journal of Clinical Medicine|April 13, 2024
Sequencing Treatments in Patients with Advanced Well-Differentiated Pancreatic Neuroendocrine Tumor (pNET): Results from a Large Multicenter Italian CohortFrancesco Panzuto, Elisa Andrini, Giuseppe Lamberti, et al.Seminars in Cancer Biology|March 30, 2025
Pancreatic neuroendocrine neoplasms (pNENs): Genetic and environmental biomarkers for risk of occurrence and prognosisMatteo Tacelli, Manuel Gentiluomo, Paolo Biamonte, et al.Journal of the National Comprehensive Cancer Network : JNCCN|May 14, 2024
Efficacy and Toxicity Analysis of mFOLFIRINOX in High-Grade Gastroenteropancreatic Neuroendocrine NeoplasmsMichele Borghesani, Anna Reni, Eleonora Lauricella, et al.Pageof 8